SE435374B - Terapeutiskt aktiva derivat av 4-(2-hydroxi-3-amino-propoxi)-indol, deras framstellning och anvendning. - Google Patents

Terapeutiskt aktiva derivat av 4-(2-hydroxi-3-amino-propoxi)-indol, deras framstellning och anvendning.

Info

Publication number
SE435374B
SE435374B SE7807753A SE7807753A SE435374B SE 435374 B SE435374 B SE 435374B SE 7807753 A SE7807753 A SE 7807753A SE 7807753 A SE7807753 A SE 7807753A SE 435374 B SE435374 B SE 435374B
Authority
SE
Sweden
Prior art keywords
carbon atoms
compounds
halogen
given above
formula
Prior art date
Application number
SE7807753A
Other languages
English (en)
Swedish (sv)
Other versions
SE7807753L (sv
Inventor
R Berthold
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH907777A external-priority patent/CH632246A5/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE7807753L publication Critical patent/SE7807753L/xx
Publication of SE435374B publication Critical patent/SE435374B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7807753A 1977-07-21 1978-07-12 Terapeutiskt aktiva derivat av 4-(2-hydroxi-3-amino-propoxi)-indol, deras framstellning och anvendning. SE435374B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH907077 1977-07-21
CH907377 1977-07-21
CH906577 1977-07-21
CH907777A CH632246A5 (en) 1977-07-21 1977-07-21 Process for preparing novel 3-aminopropoxyindoles

Publications (2)

Publication Number Publication Date
SE7807753L SE7807753L (sv) 1979-01-22
SE435374B true SE435374B (sv) 1984-09-24

Family

ID=27429188

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7807753A SE435374B (sv) 1977-07-21 1978-07-12 Terapeutiskt aktiva derivat av 4-(2-hydroxi-3-amino-propoxi)-indol, deras framstellning och anvendning.

Country Status (18)

Country Link
JP (1) JPS5422364A (nl)
AU (1) AU523105B2 (nl)
BE (1) BE869133A (nl)
CA (1) CA1098909A (nl)
DE (1) DE2830211A1 (nl)
DK (1) DK312878A (nl)
ES (1) ES471863A1 (nl)
FI (1) FI782229A (nl)
FR (1) FR2398058A1 (nl)
GB (1) GB2001971B (nl)
IE (1) IE47131B1 (nl)
IL (1) IL55170A (nl)
IT (1) IT1105092B (nl)
NL (1) NL7807626A (nl)
NZ (1) NZ187909A (nl)
PT (1) PT68317A (nl)
SE (1) SE435374B (nl)
SU (1) SU843740A3 (nl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2905877A1 (de) * 1979-02-16 1980-08-28 Boehringer Mannheim Gmbh Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3068678D1 (en) * 1979-08-10 1984-08-30 Sandoz Ag 3-aminopropoxyaryl derivatives, their preparation and pharmaceutical compositions containing them
DE3029980A1 (de) * 1980-08-08 1982-03-11 Boehringer Mannheim Gmbh, 6800 Mannheim Indolderivate und verfahren zu ihrer herstellung
DE3030047A1 (de) * 1980-08-08 1982-03-11 Boehringer Mannheim Gmbh, 6800 Mannheim Neue aminopropanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3131146A1 (de) * 1981-08-06 1983-02-24 Boehringer Mannheim Gmbh, 6800 Mannheim Neue heteroaryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
CN1254465C (zh) * 1996-04-09 2006-05-03 Nps医药公司 钙代谢化合物
US6818660B2 (en) 1996-04-09 2004-11-16 Nps Pharmaceuticals, Inc. Calcilytic compounds
DE69711519T2 (de) * 1996-09-05 2002-10-31 Eli Lilly And Co., Indianapolis Carbazolanaloge als selektive beta3-adrenergische Agonisten
US7202261B2 (en) 1996-12-03 2007-04-10 Nps Pharmaceuticals, Inc. Calcilytic compounds
TW483881B (en) 1996-12-03 2002-04-21 Nps Pharma Inc Calcilytic compounds
WO2001036412A1 (en) * 1999-11-15 2001-05-25 Eli Lilly And Company Process for the preparation of aryloxy propanolamines
MA44994A (fr) 2016-05-13 2019-03-20 Univ Leland Stanford Junior Composés de modulation des récepteurs adrénergiques et leurs procédés d'utilisation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1547056A (fr) * 1966-12-13 1968-11-22 Sandoz Sa Dérivés de l'indole et leur préparation
FR2019185A1 (en) * 1968-09-30 1970-06-26 Sandoz Sa 4-(2-hydroxy-3-amino-propoxy)-indole-2-carboxy- - lic acids and esters and 2-hydroxymethylindoles as beta
US3699123A (en) * 1970-03-24 1972-10-17 Sandoz Ltd 4-(3-amino-2-hydroxy-propoxy) indole derivatives
DE2508251C2 (de) * 1975-02-26 1983-12-29 Boehringer Mannheim Gmbh, 6800 Mannheim Derivate des Indols, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel
US4076829A (en) * 1974-11-16 1978-02-28 Boehringer Mannheim Gmbh Aminopropanol compounds and compositions for the treatment of cardiac and circulatory diseases
DE2633839A1 (de) * 1975-08-07 1977-02-24 Sandoz Ag Neue 4-aminopropoxyindolderivate, ihre herstellung und verwendung
DE2635209C2 (de) * 1975-08-15 1983-01-27 Sandoz-Patent-GmbH, 7850 Lörrach 4-(2-Benzoyloxy-3-tert.butylamino-propoxy)-2-methylindol, dessen (S)-Enantiomeres, deren Säureadditionssalze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Heilmittel

Also Published As

Publication number Publication date
JPS5422364A (en) 1979-02-20
DK312878A (da) 1979-01-22
FI782229A (fi) 1979-01-22
PT68317A (fr) 1978-08-01
NL7807626A (nl) 1979-01-23
IL55170A (en) 1982-07-30
GB2001971B (en) 1982-02-10
IT7850299A0 (it) 1978-07-14
NZ187909A (en) 1981-04-24
IE781448L (en) 1979-01-21
ES471863A1 (es) 1979-10-01
IT1105092B (it) 1985-10-28
GB2001971A (en) 1979-02-14
CA1098909A (en) 1981-04-07
AU3818278A (en) 1980-01-24
IE47131B1 (en) 1983-12-28
FR2398058B1 (nl) 1982-08-06
IL55170A0 (en) 1978-09-29
AU523105B2 (en) 1982-07-15
DE2830211A1 (de) 1979-02-01
SE7807753L (sv) 1979-01-22
SU843740A3 (ru) 1981-06-30
FR2398058A1 (fr) 1979-02-16
BE869133A (fr) 1979-01-19

Similar Documents

Publication Publication Date Title
EP0178874B1 (en) Alkylsulfonamidophenylalkylamines
SE435374B (sv) Terapeutiskt aktiva derivat av 4-(2-hydroxi-3-amino-propoxi)-indol, deras framstellning och anvendning.
KR19990077162A (ko) 신규한 3환성 화합물 및 그를 함유하는 의약 조성물
KR910006637B1 (ko) 트립타민 유도체의 제조방법
EP0166615A2 (en) Improvements in or relating to benzenesulfonamido derivatives
KR100199524B1 (ko) 엔-헤테로아릴-푸린-6-아민 및 이의 제조방법
US4381398A (en) Amino-alcohol derivatives
WO2004092127A1 (en) Process for the preparation of n-substituted 2-cyanopyrrolidines
US3825558A (en) Substituted aminopropoxy-2-indolinones
US4129656A (en) Thiazolidine derivatives, salidiuretic compositions and methods of effecting salidiuresis employing them
FR2660657A1 (fr) Nouveaux derives du 3-aminochromane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
AP694A (en) Nitro-benzamides useful as anti-arrhythmic agents.
EP0242939B1 (en) Indole derivatives
US2449638A (en) Substituted glycinamides
SE435927B (sv) Trans-4-(2-klorofenoxi)-1-etyl-pyrrolidinol med terapeutisk verkan
US4806551A (en) N-dihydroindolylethyl-sulphonamides
NO742478L (nl)
NO882065L (no) Diarylalkyl-substituerte alkylaminer, fremgangsmaate for fremstilling av dem, anvendelse av dem, saavel som legemidler som inneholder dem.
US3813398A (en) Benzenesulfonyl-semicarbazides and process for their manufacture
US3442890A (en) Substituted 3-benzazocin-16-ones
US3808231A (en) 4-(2-hydroxy-3-(2-alkynylamino)propoxy)indoles
AU738672B2 (en) Novel antiarrhythmic compounds
KR100306018B1 (ko) 약리학적 활성을 갖는 에난티오머
US3373163A (en) N-methyl-piperazides of alicyclic and heterocyclic carboxylic acids
GB2055372A (en) Texahydro-trans-pyridoindole neuroleptic agents